The video article summarizes the technique of pancreatectomy and pancreas allotransplantation in a porcine 3-day survival model with a step-by-step description of the method and emphasis on the surgical tips and tricks to deal with the precarious and delicate porcine visceral anatomy.
Despite the promising results of pancreas transplantation in type 1 diabetes mellitus and metabolic syndrome, the biggest concern around this state-of-the-art technique remains the paucity of organs deemed fit for transplantation. High intravascular resistance, delicate intraparenchymal capillary framework, and complex lobular anatomy around the mesenteric vasculature are what make this organ more susceptible to injury and less tolerant to trivial trauma compared to organs such as the liver and kidney. Meticulous surgical dissection and judicious tissue handling form the cornerstone of the entire exercise of pancreas transplantation. Owing to morphological similarity between the anatomy of the porcine pancreas to the surrounding mesenteric vessels and the organs when compared to the human anatomy, demonstration of the technique in the porcine model could help to most accurately extrapolate this to a human setting. The present article aims to outline the essential surgical tips and tricks that need to be followed, in order to ensure a higher success rate of transplantation of this highly susceptible organ in a porcine 3-day survival model.
Over the past several decades, there has been significant progress in perioperative management strategies and surgical techniques leading to the evolution of pancreas transplantation into one of the most promising strategies for the treatment of diabetes mellitus with end-stage renal disease (usually in conjunction with kidney transplantation)1. However, complications such as graft pancreatitis, ischemia-reperfusion injury, and vascular thrombosis remain the biggest challenges to overcome to ensure successful outcomes, more so in the more damaged extended criteria grafts2. In addition, pancreas grafts are the most commonly discarded grafts from procurement and have the lowest utilization rates (9%) for any organ3. Therefore, machine perfusion aims to provide an optimum homeostatic milieu to the pancreas graft with the goal of increasing graft utilization rate, similar to what has been achieved in liver, kidney, and lung transplantation4. The porcine pancreatic anatomy is complex in terms of its lobular architecture (comprising three lobes), its extensions all around the mesenterico-portal axis, its mesenteric vascular variations (in 40%-50%), and its delicate vascular channels along the C loop of the duodenum5. These anatomical attributes contribute to a challenging dissection in both retrieval of the pancreato-duodenal graft and recipient pancreatectomy to induce an iatrogenic apancreatic diabetes state, i.e., surgically induced state of diabetes mellitus with a fasting glucose level above 8 mmol/L. Based on these features, porcine pancreatectomy with transplantation provides the closest possible replication of the technique that could be performed in humans as a definitive treatment against end-stage diabetes mellitus. The present article aims at covering the following aspects: (i) outline of the peri-operative porcine care during recipient pancreatectomy and pancreas graft implantation; (ii) technical step by step details of the recipient pancreatectomy and implantation of the pancreato-duodenal graft and (iii) tips and tricks of donor and recipient pancreatic operation in porcine models to minimize graft and recipient injury.
The protocol received ethical approval from the Animal Care Committee, Toronto general research institute. Animals received humane care in compliance with the National Society of Medical Research and Guide for the care of laboratory animals, National Institute of Health (NIH), Ontario, Canada. For this study, 15-week-old unrelated Yorkshire male swine, weighing 40-50 kg were used.
NOTE: The entire protocol of the study is divided into the following major steps: (i) Organ retrieval and back-table preparation; (ii) Recipient total pancreatectomy and (iii) Graft implantation. The entire surgery of donor and recipient is done in 1 day.
1. Donor organ retrieval and back-table preparation
NOTE: The method for organ retrieval has been described in a separate protocol6. However, the protocol, in brief, is described here along with some additional take-home points specific to the surgical technique (surgical tips relevant to donor operation).
2. Recipient pancreatectomy
Figure 1: Pancreatectomy specimen resected en masse. Note the ring of pancreatic tissue surrounding the portal vein in vivo. Please click here to view a larger version of this figure.
Figure 2: Image of the duodenum. The C loop of the duodenum with a preserved vascular arcade (arrowhead) compared with the surrounding jejunal loop and assessed for congestion. Please click here to view a larger version of this figure.
The peri-operative and post-operative, up to 3-day, biochemical parameters from the five pancreas transplant survival models are summarized below (numbered as PTX 1 to 5 in chronology). Of the five total pancreas transplants, all fared well during the 3-day survival period, as evident by their general well-being and the pancreatic injury and endocrine function tests. The results depicted below are representative of the experience of a 3-day survival model of recipient pancreatectomy followed by pancreas allotransplantation after static cold storage of the graft.
The average operating time for the pancreatectomy was 52 min (45-64 min). Since this was a brain-dead heart beating model, there was no asystolic warm ischemia phase in the donor. The average recipient warm ischemia time from applying the side-biting cava clamp to reperfusion of the graft was 49.5 min (40-55 min). All the five grafts had a cold ischemia time of 5 hrs (300 mins) as per the study protocol. All animals received immunosuppression in the form of 300 mg Syp cyclosporine, twice a day.
Peri-operative clinical and biochemical parameters
The mean heart rate 1 h after reperfusion was 135 beats/min (120-170 beats/min). The mean blood pressure was 37 mmHg (30-55 mmHg), usually maintained under the cover of a high dose of norepinephrine infusion. In all five cases, the norepinephrine could be tapered and discontinued before shifting the animal back to its pen. The lactate levels were monitored in the operating room for 3 h after reperfusion. The trend is represented in Figure 3.
Figure 3: Serum lactate levels after reperfusion of graft. The trend was measured for the first 3 h of reperfusion. Y-axis represents the lactate values (in mmol/L). Please click here to view a larger version of this figure.
Post-operative clinical and pancreatic injury biochemical parameters
All five animals were clinically alert, evident by active movement of limbs and breathing patterns, within 5-6 h of reperfusion. All of them were active, accepted oral feeds and medications, and passed urine and stools by the morning of postoperative day 1.
The post-operative amylase levels over the first 3 days are summarized in Figure 4.
Figure 4: Serum amylase levels after reperfusion of graft. The trend was measured for the first 3 days after transplantation. Y-axis represents the amylase levels (U/L). Please click here to view a larger version of this figure.
The postoperative serum lipase levels over the first 3 days are summarized in Figure 5.
Figure 5: Serum lipase levels after reperfusion of graft. The trend was measured for the first 3 days after transplantation. Y-axis represents the lipase levels (U/L). Please click here to view a larger version of this figure.
The postoperative serum lactate dehydrogenase (LDH) levels are summarized below in Figure 6.
Figure 6: Serum LDH levels after reperfusion of graft. The trend was measured for the first3 days after transplantation. Y-axis represents the LDH levels (U/L). Please click here to view a larger version of this figure.
Post-operative glucose tolerance test
A 120 min IV glucose tolerance test was performed on the third post-operative day. A 50 mL dose containing 50% dextrose was injected through the central venous catheter and the time was recorded as 0 min. Blood samples were withdrawn subsequently at 2 min, 5 min, 10 min, 20 min, 30 min, 60 min, 90 min, and 120 min and processed for glucose levels. The remainder of the sample was centrifuged at 8,000 x g for 10 min and the supernatant was stored in three microcentrifuge tubes at -80 °C. Figure 7 represents the trend of the glucose tolerance test for the five cases (PTX 1-5).
Figure 7: Serum glucose levels as assessed by the IV Glucose tolerance test. The serum glucose levels were assessed 0-120 min by using the IV Glucose tolerance test and were compared between PTX 1-5. Y-axis represents the glucose levels (mmol/L). Please click here to view a larger version of this figure.
The current protocol has been performed to demonstrate the technique and the feasibility of pancreatectomy and pancreas allotransplantation in porcine models. The animals were observed for a period of 3 days after transplantation to demonstrate the reliability of the technique of pancreatectomy and the allotransplantation. All animals were monitored and nursed for 3 days after the surgery using a standardized animal care protocol of antibiotics, fluids, analgesics, supplemental nutrition, and immunosuppressants (i.e., cyclosporine). They were sacrificed on the third postoperative day (after 72 h or earlier if mandated by clinical deterioration) by ethically approved humane technique. Biopsies were taken from the tail, corpus, head, and duodenum and sent for histopathological analysis, and the remaining sections were stored in RNA isolation buffer, and snap-frozen (- 80 °C) for later use.
One of the earliest attempts at successfully demonstrating induction of iatrogenic diabetes mellitus in the porcine model by pancreatectomy was published by Chaiba et al. in 2011 in a cohort of 10 white male swine weighing 27-33 kg7. The group demonstrated the anatomical planes and landmarks establishing a roadmap for successful pancreatectomy in swine models. Prudhomme et al. in 2020 demonstrated the feasibility of diabetes induction and pancreas allotransplantation in their cohort of three male Susscrofa pigs8. The induction of diabetes was assessed by C peptide levels 3 h after total pancreatectomy. Medical induction of diabetes mellitus in Yorkshire pigs was demonstrated successfully by Grussner et al. in 1993 with a mortality rate of 0% in a cohort of 67 Yorkshire landrace pigs9. Successful induction of diabetes by pancreatectomy was assessed using serum glucose levels, guided by the clinical wellbeing of the animal by our group (Mazilescu et al.) in 202210. Following the establishment of successful induction, our group proceeded with pancreas allotransplantation following pancreatectomy in the subsequent phase of the protocol.
An important limitation of the study is ensuring uniform replicability in all cohorts of the animals. This is mainly because of the fragility of the porcine model in terms of being prone to seasonal flu, zoonosis, etc. These factors might contribute to negatively skewing the results irrespective of the technique being used for surgery.
The factors affecting the outcome of pancreas transplantation include pre-operative conditions such as general well-being, cardiopulmonary status, seasonal infection, and peri-operative conditions such as the status of the graft at the end of machine perfusion, graft handling during surgery, hemodynamic alterations at reperfusion11. From a surgical point of view, minimizing graft handling in vivo and ex situ play an important role in ensuring the implantation of a minimally damaged graft in this highly precarious model of transplantation12. Modifications in the composition of the perfusion solution, dialyzing solution, and physiological parameters during machine perfusion might also determine the outcome of transplantation and are currently under evaluation by the group. The establishment of a successful allotransplantation model in machine perfused grafts could further pave the path for extended criteria grafts such as donation after cardiac death (DCD) and extended cold storage (ECS) of pancreases in the future.
The authors have nothing to disclose.
None.
Belzer UW Cold storage solution | Bridge to life Ltd (Columbia, SC, USA) | 4055 | |
Calcium gluconate (10%) | Fresenius Kabi Canada Ltd (Toronto, ON) | C360019 | |
Composelect (blood collection bags) | Fresenius Kabi Canada Ltd (Toronto, ON) | PQ31555 | |
Heparin (10000 IU/10 ml) | Fresenius Kabi Canada Ltd (Toronto, ON) | C504710 | |
Lactated Ringer's | Baxter (Mississauga, ON, Canada) | JB2324 | |
Percutaneous Sheath Introducer Set with Integral Hemostasis Valve/side Port for use with 7-7.5 Fr Catheters | Arrow International LLC | SI-09880 | |
Sodium bicarbonate (8.4%) | Fresenius Kabi Canada Ltd (Toronto, ON) | C908950 | |
Solu-Medrol | Pfizer Canada Inc. | 52246-14-2 | |
Surgical retreival and transplant instrument set |